Home > Press > H&H Group Invests Additional $2,500,000 in Molecular Imprints
Total investment in Molecular Imprints $4.5 million
Harris & Harris Group Invests Additional $2,500,000 in Molecular Imprints
September 21, 2005
Harris & Harris Group, Inc.®, announced today that it invested an
additional $2,500,000 in privately held Molecular Imprints, Inc., of
Austin, TX, bringing its total investment in Molecular Imprints to
$4,500,000. The investment was as part of a Series C financing that
raised $17 million in the first closing of a planned $25 million
Series C financing. Molecular Imprints provides enabling
lithography systems for manufacturing applications in: nano devices,
LEDs for solid state lighting, magnetic data storage for micro disk
drives and others. Other investors participating in this financing
include Dai Nippon Printing Company (DNP), Alloy Ventures, Motorola
Ventures, Draper Fisher Jurvetson, Hakuto Co., Ltd., Asset
Management and others. Molecular Imprints will use the money to
expand its Imprio® product line.
Harris & Harris Group is a publicly traded venture capital company
that now makes initial investments exclusively in tiny technology,
including nanotechnology, microsystems and microelectromechanical
systems (MEMS). The Company's last 24 initial private equity
investments have been in tiny-technology enabled companies. The
Company has 20,756,345 shares of common stock outstanding.
Detailed information about Harris & Harris Group and its holdings
can be found on its website at www.TinyTechVC.com.
This press release may contain statements of a forward-looking
nature relating to future events. These forward-looking statements
are subject to the inherent uncertainties in predicting future
results and conditions. These statements reflect the Company's
current beliefs, and a number of important factors could cause
actual results to differ materially from those expressed in this
press release. Please see the Company's Annual Report on Form 10-K
for the fiscal year ended December 31, 2004, filed with the
Securities and Exchange Commission, for a more detailed discussion
of the risks and uncertainties associated with the Company's
business, including but not limited to the risks and uncertainties
associated with venture capital investing and other significant
factors that could affect the Company's actual results. Except as
otherwise required by Federal securities laws, Harris & Harris
Group, Inc.®, undertakes no obligation to update or revise these
forward-looking statements to reflect new events or uncertainties.
The reference to the website www.TinyTechVC.com has been provided as
a convenience, and the information contained on such website is not
incorporated by reference into this press release.
Copyright © Harris & Harris Group
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Nanometrics Announces Upcoming Investor Events July 20th, 2016
Keystone Nano selected as a top scoring company by NCI investor review panel July 19th, 2016
Arrowhead Pharmaceuticals to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference July 6th, 2016
Nanometrics to Participate in the 8th Annual CEO Investor Summit: Investor Event Held Concurrently with SEMICON West 2016 in San Francisco June 22nd, 2016
Vortex laser offers hope for Moore's Law: The optics advancement may solve an approaching data bottleneck by helping to boost computing power and information transfer rates tenfold July 30th, 2016
New method for making green LEDs enhances their efficiency and brightness July 30th, 2016
Novel state of matter: Observation of a quantum spin liquid July 29th, 2016
A new type of quantum bits July 29th, 2016